Searched for
INSULIN SUPPLY GAP
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
- 'GLP-1 made for US': Medanta founder Dr. Naresh Trehan explains risks for Indians using weight-loss drugsGLP-1 weight loss drugs: Renowned cardiovascular surgeon Dr. Naresh Trehan has issued a stern warning against the unsupervised use of GLP-1...
- We need to quickly get OzempickyAffordable semaglutide generics are coming to India. This drug helps with diabetes and weight loss. Millions need it for health issues. How...
- Best medicine for volatile times: Don’t buy a stock, buy a business; 5 pharma stocks with upside potential of up to 43%Don’t buy a stock, buy a business, says our headline. It’s not as easy as it sounds. But it’s not too difficult either. While there are sev...
- Pharma sector: Look beyond the tariff reprieve for generics. 6 mid-cap pharma stocks with an upside potential of more than 23%With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tar...
- Novo Nordisk to phase out key drug, insulin cos spot big biz opportunityNovo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the a...
- 12 stocks that are BofA Securities' top buys from 7 sectors. Do you own them?While BofA remained overweight on select domestic cyclicals such as industrials, financials and automobile stocks, it has marginally trimme...
- Text of President Joe Biden's State of the Union addressMadam Speaker, Madam Vice President, our First Lady and Second Gentleman. Members of Congress and the Cabinet. Justices of the Supreme Cour...
- What's inside Joe Biden's $1.85T social and climate measureThe bill will still have to clear the Senate, where revisions are nearly certain. But Democrats are aiming to get it to Biden's desk by Chr...
- We're here to stay, open to buy right portfolio: Rajiv Malik, President, MylanMylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.
- STMicroelectronics sees huge potential in India's medical devices market: Vivek SharmaIn an interview with ET, Sharma talked about why the changes are important for India and how the firm is moving into this nascent-but-growi...
Load More
